- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05357768
Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project (GRACefUl)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Emanuela Palmerini, MD
- Phone Number: 199 051.63.66
- Email: emanuela.palmerini@ior.it
Study Contact Backup
- Name: Marco Gambarotti, MD
- Phone Number: 652 051.63.66
- Email: marco.gambarotti@ior.it
Study Locations
-
-
BO
-
Bologna, BO, Italy, 40136
- Recruiting
- IRCCS Istituto Ortopedico Rizzoli
-
Principal Investigator:
- Emanuela Palmerini, MD
-
Contact:
- Emanuela Palmerini, MD
- Phone Number: 199 051.63.66
- Email: emanuela.palmerini@ior.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with undifferentiated round cell sarcomas treated from 01 January 1983 and all new patients will be included.
- Clinical and outcome information available.
- Histological slides/formalin-fixed paraffin-embedded tissue tumor blocks from archive available to perform the histology analysis/frozen tissue representative of the tumor available.
Exclusion Criteria:
- Diagnosis different from undifferentiated round cell sarcomas
- Patient with no clinical or outcome information available
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
retrospective cohort
Patients with undifferentiated round cell sarcomas treated from 01 January 1983 to April 2019 will be included. For retrospective analysis, it is expected to include about 200 patients. |
Formalin-fixed paraffin embedded tissue and/or frozen tumoral tissue of cases negative for all Ewing's sarcoma molecular fusions, will be analyzed for the presence of CIC-DUX4 / BCOR-CCNB3 translocations fusion at each Institution. Treatment, outcome, and prognostic factors will be related with the molecular re-classification. |
prospective cohort
prospective patients with undifferentiated round cell sarcomas will be included in the study.
For prospective study, it is expect to include 60 patients.
|
Formalin-fixed paraffin embedded tissue and/or frozen tumoral tissue of cases negative for all Ewing's sarcoma molecular fusions, will be analyzed for the presence of CIC-DUX4 / BCOR-CCNB3 translocations fusion at each Institution. Treatment, outcome, and prognostic factors will be related with the molecular re-classification. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
event free survival
Time Frame: baseline
|
Correlate clinical and pathological variables with event-free survival and overall-survival in undifferentiated round cell sarcomas.
|
baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GRACefUl
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Undifferentiated Round Cell Sarcoma
-
Fred Hutchinson Cancer CenterIncyte CorporationActive, not recruitingRefractory Soft Tissue Sarcoma | Metastatic Leiomyosarcoma | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Advanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Advanced Synovial Sarcoma | Metastatic Chondrosarcoma | Advanced Leiomyosarcoma | Metastatic Myxoid... and other conditionsUnited States
-
Institut BergoniéRecruitingSoft Tissue Sarcoma Adult | Solitary Fibrous Tumors | Hemangioendothelioma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Epithelioid Sarcoma | Desmoplastic Round Cell TumorFrance
-
GlaxoSmithKlineTerminatedNeoplasmsUnited States, Germany, Netherlands, Canada, Australia, Sweden
-
GlaxoSmithKlineActive, not recruitingNeoplasmsUnited States, Netherlands, Canada, United Kingdom
-
GlaxoSmithKlineCompleted
-
Immune DesignGenentech, Inc.TerminatedSarcoma | Myxoid/Round Cell Liposarcoma | Liposarcoma | Synovial Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Metastatic Sarcoma | Locally Advanced SarcomaUnited States
-
M.D. Anderson Cancer CenterSuspendedMyxoid/Round Cell Liposarcoma | Synovial SarcomaUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingSarcoma | Desmoplastic Small Round Cell Tumor (DSRCT)United States
-
Novartis PharmaceuticalsCompletedRefractory Desmoplastic Small Round Cell TumorsItaly
-
Children's Hospital of PhiladelphiaJazz Pharmaceuticals; Stand Up To CancerRecruitingEwing Sarcoma | Pediatric Cancer | Desmoplastic Small Round Cell Tumor | Undifferentiated SarcomaUnited States
Clinical Trials on data collection and analysis on Formalin-fixed paraffin embedded tissue and/or frozen tumoral tissue
-
IRCCS San RaffaeleNot yet recruiting
-
Hellenic Cooperative Oncology GroupHellenic Society of Medical OncologyActive, not recruitingMetastatic Breast CancerGreece
-
CHU de ReimsCompleted
-
Istituto Clinico HumanitasUnknown
-
Janssen Research & Development, LLCCompletedMetastatic Prostate CancerUnited States, Korea, Republic of, Australia, Poland, Taiwan, France, Thailand, Malaysia, Russian Federation, Canada, Bulgaria, Italy, Spain, Turkey, Sweden, Israel, Belarus, Ukraine, Brazil, Argentina, Belgium, Denmark, United Kingdom and more
-
Parc de Salut MarGUARDANT HEALTHRecruitingLung Cancer | Stage III Lung Cancer | Unresectable Lung CarcinomaSpain